The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Clincal and Experimental Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1336720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Langerhans cells in epidermotropism of T cells

  2004cited by this paper
• Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin.

  1991cited by this paper
• Distribution of CD1a-positive cells in psoriatic skin during the evolution of the lesions.

  1989cited by this paper
• Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections.

  1989cited by this paper
• Diagnosis of renal allograft rejection by macrophage immunostaining with a CD14 monoclonal antibody, WT14.

  1989cited by this paper
• Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity.

  1989cited by this paper
• Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.

  1988cited by this paper
• The pathomechanisms of psoriasis; the skin immune system and cyclosporin

  1988cited by this paper
• Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis.

  1987cited by this paper
• Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin

  1987cited by this paper
• Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.

  1986cited by this paper
• Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4

  1986cited by this paper
• Elastase, a marker for neutrophils in skin infiltrates

  1986cited by this paper
• Monoclonal antibodies to various acidic (type I) cytokeratins of stratified epithelia. Selective markers for stratification and squamous cell carcinomas.

  1986cited by this paper
• Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes

  1985cited by this paper
• Arachidonic acid and leukotrienes in clinical dermatology.

  1985cited by this paper
• Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes

  1984cited by this paper
• Production of intraepidermal microabscesses by topical application of leukotriene B4.

  1984cited by this paper
• Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.

  1984cited by this paper
• Leukotriene B: a potential mediator of inflammation

  1980cited by this paper
• Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB.

  1980cited by this paper
• Uptake, intracellular transport and degradation of exogenous protein by Langerhans cells. An electron microscopic-cytochemical study using peroxidase as tracer substance.

  1970cited by this paper

• Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Pro-Inflammatory Leukotriene B4.

  2020cites this paper
• Application of leukotriene B4 and reflectance confocal microscopy as a noninvasive in vivo model to study the dynamics of skin inflammation

  2015cites this paper
• Leukotrienes do not modulate the course of Aldara™-induced psoriasiform dermatitis in mice.

  2015cites this paper
• Cutaneous Application of Leukotriene B4 as an in vivo Model of Psoriasis-Like Skin Inflammation: An Immunohistological Study

  2014cites this paper
• In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.

  2014cites this paper
• IL-17 in psoriasis: from T cells to neutrophils

  2014cites this paper
• Leukotriene B4-driven neutrophil recruitment to the skin is essential for allergic skin inflammation.

  2012cites this paper
• Inhibitory Effect of a Potent and Selective Cytosolic Phospholipase A2α Inhibitor RSC-3388 on Skin Inflammation in Mice

  2008cites this paper
• Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors.

  2006cites this paper
• The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans.

  2006cites this paper
• antigen-primed T cells in humans lipid chemoattractant receptor BLT 1 defines 4 The leukotriene B

  2005cites this paper
• T-cell trafficking in asthma: lipid mediators grease the way

  2004cites this paper
• BLT1 and BLT2: the leukotriene B(4) receptors.

  2003cites this paper
• Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment

  2003cites this paper
• Dermo-epidermal stimulation elicited by a salicylic acid derivative: a comparison with salicylic acid and all trans-retinoic acid.

  2002cites this paper
• Atypical lambda/iota PKC conveys 5-lipoxygenase/leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-kappa B activation in response to tumor necrosis factor-alpha and interleukin-1beta.

  2001cites this paper
• Functional coupling between secretory and cytosolic phospholipase A2 modulates tumor necrosis factor-alpha- and interleukin-1beta-induced NF-kappa B activation.

  2001cites this paper
• Pathophysiological role of leukotrienes in dermatological diseases: potential therapeutic implications.

  2001cites this paper
• Expression and function of beta 2 integrin CD11B/CD18 on leukocytes from patients with psoriasis.

  1999cites this paper
• Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis

  1998cites this paper
• The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).

  1997cites this paper
• Dermo-epidermal stimulation elicited by a beta-lipohydroxyacid: a comparison with salicylic acid and all-trans-retinoic acid.

  1997cites this paper
• Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions

  1997cites this paper
• The immunohistochemical effects of a single challenge with an intermediate dose of ultravilet B on normal human skin

  1996cites this paper
• Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.

  1996cites this paper
• Rearrangement of S-100 immunoreactive Langerhans' cells in human psoriatic skin treated with peptide T.

  1995cites this paper
• Dermal inflammation in primates, mice, and guinea pigs: Attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228

  1995cites this paper
• Molecular and cell biological characterization of the serine proteinase inhibitor SKALP

  1995cites this paper
• The dynamics of the response of normal skin to single and multiple epicutaneous leukotriene B4 applications analysed by three-colour flow cytometry.

  1995cites this paper
• SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.

  1994cites this paper